Cargando…
Identification of MicroRNA–mRNA Networks in Melanoma and Their Association with PD-1 Checkpoint Blockade Outcomes
SIMPLE SUMMARY: We conducted a network analysis of microRNA–mRNA associations in melanoma tissue and cell lines to identify the microRNAs central to melanoma biology and their associated gene expression profiles. Further, we evaluated expression of these microRNAs in melanoma patient biopsies and fo...
Autores principales: | Sloane, Robert A. Szczepaniak, White, Michael G., Witt, Russell G., Banerjee, Anik, Davies, Michael A., Han, Guangchun, Burton, Elizabeth, Ajami, Nadim, Simon, Julie M., Bernatchez, Chantale, Haydu, Lauren E., Tawbi, Hussein A., Gershenwald, Jeffrey E., Keung, Emily, Ross, Merrick, McQuade, Jennifer, Amaria, Rodabe N., Wani, Khalida, Lazar, Alexander J., Woodman, Scott E., Wang, Linghua, Andrews, Miles C., Wargo, Jennifer A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582574/ https://www.ncbi.nlm.nih.gov/pubmed/34771465 http://dx.doi.org/10.3390/cancers13215301 |
Ejemplares similares
-
The efficacy of anti‐programmed cell death protein 1 therapy among patients with metastatic acral and metastatic mucosal melanoma
por: Ogata, Dai, et al.
Publicado: (2021) -
TIL therapy and anti-CTLA4: can they co-exist?
por: Forget, Marie-Andrée, et al.
Publicado: (2019) -
Intra-patient intra-tumoral immune heterogeneity is evident at progression on targeted therapy and immunotherapy for melanoma
por: Reuben, Alexandre, et al.
Publicado: (2014) -
Evidence of synergy with combined BRAF-targeted therapy and immune checkpoint blockade for metastatic melanoma
por: Cooper, Zachary A, et al.
Publicado: (2014) -
Update on use of aldesleukin for treatment of high-risk metastatic melanoma
por: Amaria, Rodabe N, et al.
Publicado: (2015)